Mechanisms of increased bioavailability through amorphous solid dispersions: a review

References

• Aboelwafa AA, Fahmy RH. (2012). A pilot human pharmacokinetic study and influence of formulation factors on orodispersible tablet incorporating meloxicam solid dispersion using factorial design. Pharm Dev Technol 17:1–14.
   PubMed Web of Science ®Google Scholar
• Agrawal AM, Dudhedia MS, Zimny E. (2016). Hot melt extrusion: development of an amorphous solid dispersion for an insoluble drug from mini-scale to clinical scale. AAPS PharmSciTech 17:133–47.
   PubMed Web of Science ®Google Scholar
• Aleandri S, Jankovic S, Kuentz M. (2018). Towards a better understanding of solid dispersions in aqueous environment by a fluorescence quenching approach. Int J Pharm 550:130–9.
   PubMedGoogle Scholar
• Alonzo DE, Raina S, Zhou D, et al. (2012). Characterizing the impact of hydroxypropylmethyl cellulose on the growth and nucleation kinetics of felodipine from supersaturated solutions. Cryst Growth Des 12:1538–47.
   Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413–20.
   PubMed Web of Science ®Google Scholar
• Anon. (2014). Abstracts of the Dutch Society of Clinical Pharmacology and Biopharmacy meeting of March 26, 2013: Clinical Pharmacology and Biopharmacy meeting of March 26, 2013. Br J Clin Pharmacol 78:763–75.
   Google Scholar
• Arca HC, Mosquera-Giraldo LI, Dahal D, et al. (2017). Multidrug, anti-HIV amorphous solid dispersions: nature and mechanisms of impacts of drugs on each other’s solution concentrations. Mol Pharm 14:3617–27.
   PubMedGoogle Scholar
• Baghel S, Cathcart H, O'Reilly NJ. (2016). Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J Pharm Sci 105:2527–44.
   PubMed Web of Science ®Google Scholar
• Baghel S, Cathcart H, O’Reilly NJ. (2018). Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and 1H NMR. Int J Pharm 536:414–25.
   PubMedGoogle Scholar
• Baird JA, Van Eerdenbrugh B, Taylor LS. (2010). A classification system to assess the crystallization tendency of organic molecules from undercooled melts. J Pharm Sci 99:3787–806.
   PubMed Web of Science ®Google Scholar
• Beig A, Fine-Shamir N, Lindley D, et al. (2017). Advantageous solubility-permeability interplay when using amorphous solid dispersion (ASD) formulation for the BCS class IV P-gp substrate rifaximin: simultaneous increase of both the solubility and the permeability. AAPS J 19:806–13.
   PubMed Web of Science ®Google Scholar
• Bevernage J, Brouwers J, Annaert P, Augustijns P. (2012). Drug precipitation–permeation interplay: supersaturation in an absorptive environment. Eur J Pharm Biopharm 82:424–8.
   PubMed Web of Science ®Google Scholar
• Buckley ST, Frank KJ, Fricker G, Brandl M. (2013). Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations”. Eur J Pharm Sci 50:8–16.
   PubMed Web of Science ®Google Scholar
• Chaudhari SP, Dugar RP. (2017). Application of surfactants in solid dispersion technology for improving solubility of poorly water soluble drugs. J Drug Deliv Sci Technol 41:68–77.
   Web of Science ®Google Scholar
• Chauhan H, Hui-Gu C, Atef E. (2013). Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions. J Pharm Sci 102:1924–35.
   PubMed Web of Science ®Google Scholar
• Cheng J, Wu ZH, Ping QN, et al. (2010). The absorption characteristics of bifendate solid dispersion in rat intestinal tissue. Drug Dev Ind Pharm 36:283–91.
   PubMed Web of Science ®Google Scholar
• Chen J, Mosquera-Giraldo LI, Ormes JD, et al. (2015a). Bile salts as crystallization inhibitors of supersaturated solutions of poorly water-soluble compounds. Cryst Growth Des 15:2593–7.
   Web of Science ®Google Scholar
• Chen J, Ormes JD, Higgins JD, Taylor LS. (2015b). Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles. Mol Pharm 12:533–41.
   PubMedGoogle Scholar
• Chen Y, Wang S, Wang S, et al. (2016a). Initial drug dissolution from amorphous solid dispersions controlled by polymer dissolution and drug–polymer interaction. Pharm Res 33:2445–58.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang S, Wang S, et al. (2016b). Sodium lauryl sulfate competitively interacts with HPMC-AS and consequently reduces oral bioavailability of posaconazole/HPMC-AS amorphous solid dispersion. Mol Pharm 13:2787–95.
   PubMedGoogle Scholar
• Craig DQM. (2002). The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 231:131–44.
   PubMed Web of Science ®Google Scholar
• Cui X, Mao S, Liu M, et al. (2008). Mechanism of surfactant micelle formation. Langmuir 24:10771–5.
   PubMed Web of Science ®Google Scholar
• Curatolo W, Nightingale JA, Herbig SM. (2009). Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu. Pharm Res 26:1419–31.
   PubMed Web of Science ®Google Scholar
• Dahan A, Miller JM, Hoffman A, et al. (2010). The solubility–permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone. J Pharm Sci 99:2739–49.
   PubMed Web of Science ®Google Scholar
• Dahlberg C, Millqvist-Fureby A, Schuleit M, Furó I. (2010a). Polymer–drug interactions and wetting of solid dispersions. Eur J Pharm Sci 39:125–33.
   PubMed Web of Science ®Google Scholar
• Dahlberg C, Millqvist-Fureby A, Schuleit M, Furó I. (2010b). Relationships between solid dispersion preparation process, particle size and drug release – an NMR and NMR microimaging study. Eur J Pharm Biopharm 76:311–9.
   PubMed Web of Science ®Google Scholar
• Dalsin MC, Tale S, Reineke TM. (2014). Solution-state polymer assemblies influence BCS class II drug dissolution and supersaturation maintenance. Biomacromolecules 15:500–11.
   PubMed Web of Science ®Google Scholar
• Deng L, Wang Y, Gong T, et al. (2017). Dissolution and bioavailability enhancement of alpha-asarone by solid dispersions via oral administration. Drug Dev Ind Pharm 43:1817–26.
   PubMed Web of Science ®Google Scholar
• Feng D, Peng T, Huang Z, et al. (2018). Polymer–surfactant system based amorphous solid dispersion: precipitation inhibition and bioavailability enhancement of itraconazole. Pharmaceutics 10:53.
   PubMed Web of Science ®Google Scholar
• Fischer D, Breitenbach J, eds. (2013). Die pharmaindustrie: einblick – durchblick – perspektiven. 4th ed. Deutschland: Springer Spektrum. Available at: https://www.springer.com/de/book/9783662546550 [last accessed 3 Jul 2019].
   Google Scholar
• Fong SYK, Bauer-Brandl A, Brandl M. (2017). Oral bioavailability enhancement through supersaturation: an update and meta-analysis. Expert Opin Drug Deliv 14:403–26.
   PubMed Web of Science ®Google Scholar
• Fong SYK, Martins SM, Brandl M, Bauer-Brandl A. (2016). Solid phospholipid dispersions for oral delivery of poorly soluble drugs: investigation into celecoxib incorporation and solubility-in vitro permeability enhancement. J Pharm Sci 105:1113–23.
   PubMed Web of Science ®Google Scholar
• Fotaki N, Long CM, Tang K, Chokshi H. (2014). Dissolution of amorphous solid dispersions: theory and practice. In: Shah N, Sandhu H, Choi D, eds. Amorphous solid dispersions: theory and practice. New York, NY: Springer. Available at: https://researchportal.bath.ac.uk/en/publications/dissolution-of-amorphous-solid-dispersions-theory-and-practice [last accessed 7 Dec 2019].
   Google Scholar
• Frank KJ, Westedt U, Rosenblatt KM, et al. (2012). The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility. Int J Nanomedicine 7:5757–68.
   PubMed Web of Science ®Google Scholar
• Frank KJ, Westedt U, Rosenblatt KM, et al. (2014). What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion? J Pharm Sci 103:1779–86.
   PubMed Web of Science ®Google Scholar
• Fule R, Dhamecha D, Maniruzzaman M, et al. (2015). Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): evaluating amorphous state and in vivo performance. Int J Pharm 496:137–56.
   PubMedGoogle Scholar
• Fule R, Paithankar V, Amin P. (2016). Hot melt extrusion based solid solution approach: exploring polymer comparison, physicochemical characterization and in-vivo evaluation. Int J Pharm 499:280–94.
   PubMedGoogle Scholar
• Ghebremeskel AN, Vemavarapu C, Lodaya M. (2007). Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer–surfactant combinations using solubility parameters and testing the processability. Int J Pharm 328:119–29.
   PubMed Web of Science ®Google Scholar
• Girdhar A, Thakur PS, Sheokand S, Bansal AK. (2018). Permeability behavior of nanocrystalline solid dispersion of dipyridamole generated using NanoCrySP technology. Pharmaceutics 10:160.
   PubMed Web of Science ®Google Scholar
• Han YR, Lee PI. (2017). Effect of extent of supersaturation on the evolution of kinetic solubility profiles. Mol Pharm 14:206–20.
   PubMed Web of Science ®Google Scholar
• Hou Y, Wang H, Zhang F, et al. (2019). Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin. Int J Nanomedicine 14:557–71.
   PubMed Web of Science ®Google Scholar
• Huang Y, Dai WG. (2014). Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta Pharm Sin B 4:18–25.
   PubMed Web of Science ®Google Scholar
• Huang R, Han J, Wang R, et al. (2019). Surfactant-free solid dispersion of BCS class IV drug in an amorphous chitosan oligosaccharide matrix for concomitant dissolution in vitro – permeability increase. Eur J Pharm Sci 130:147–55.
   PubMed Web of Science ®Google Scholar
• Ilevbare GA, Liu H, Edgar KJ, Taylor LS. (2012a). Effect of binary additive combinations on solution crystal growth of the poorly water-soluble drug, ritonavir. Cryst Growth Des 12:6050–60.
   Web of Science ®Google Scholar
• Ilevbare GA, Liu H, Edgar KJ, Taylor LS. (2012b). Understanding polymer properties important for crystal growth inhibition—impact of chemically diverse polymers on solution crystal growth of ritonavir. Cryst Growth Des 12:3133–43.
   Web of Science ®Google Scholar
• Ilevbare GA, Liu H, Pereira J, et al. (2013). Influence of additives on the properties of nanodroplets formed in highly supersaturated aqueous solutions of ritonavir. Mol Pharm 10:3392–403.
   PubMed Web of Science ®Google Scholar
• Ilevbare GA, Taylor LS. (2013). Liquid–liquid phase separation in highly supersaturated aqueous solutions of poorly water-soluble drugs: implications for solubility enhancing formulations. Cryst Growth Des 13:1497–1509.
   Web of Science ®Google Scholar
• Indulkar AS, Gao Y, Raina SA, et al. (2016). Exploiting the phenomenon of liquid–liquid phase separation for enhanced and sustained membrane transport of a poorly water-soluble drug. Mol Pharm 13:2059–69.
   PubMed Web of Science ®Google Scholar
• Indulkar AS, Waters JE, Mo H, et al. (2017). Origin of nanodroplet formation upon dissolution of an amorphous solid dispersion: a mechanistic isotope scrambling study. J Pharm Sci 106:1998–2008.
   PubMed Web of Science ®Google Scholar
• Jacobsen AC, Elvang PA, Bauer-Brandl A, Brandl M. (2019). A dynamic in vitro permeation study on solid mono- and diacyl-phospholipid dispersions of celecoxib. Eur J Pharm Sci 127:199–207.
   PubMed Web of Science ®Google Scholar
• Kanzer J, Hupfeld S, Vasskog T, et al. (2010). In situ formation of nanoparticles upon dispersion of melt extrudate formulations in aqueous medium assessed by asymmetrical flow field-flow fractionation. J Pharm Biomed Anal 53:359–65.
   PubMed Web of Science ®Google Scholar
• Kate L, Gokarna V, Borhade V, et al. (2016). Bioavailability enhancement of atovaquone using hot melt extrusion technology. Eur J Pharm Sci 86:103–14.
   PubMed Web of Science ®Google Scholar
• Kaushal AM, Gupta P, Bansal AK. (2004). Amorphous drug delivery systems: molecular aspects, design, and performance. Crit Rev Ther Drug Carr Syst 21:133–93.
   PubMedGoogle Scholar
• Kesisoglou F, Wang M, Galipeau K, et al. (2019). Effect of amorphous nanoparticle size on bioavailability of anacetrapib in dogs. J Pharm Sci 108:2917–2925.
   PubMed Web of Science ®Google Scholar
• Khan J, Rades T, Boyd B. (2016). The precipitation behavior of poorly water-soluble drugs with an emphasis on the digestion of lipid based formulations. Pharm Res 33:548–62.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Lee HK, Na YG, et al. (2019). A novel composition of ticagrelor by solid dispersion technique for increasing solubility and intestinal permeability. Int J Pharm 555:11–8.
   PubMed Web of Science ®Google Scholar
• Knopp MM, Wendelboe J, Holm R, Rades T. (2018). Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion. Eur J Pharm Biopharm 130:290–5.
   PubMed Web of Science ®Google Scholar
• Kojima T, Higashi K, Suzuki T, et al. (2012). Stabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT® EPO. Pharm Res 29:2777–91.
   PubMed Web of Science ®Google Scholar
• Krishna G, Ma L, Martinho M, et al. (2012). A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers. J Antimicrob Chemother 67:2725–30.
   PubMed Web of Science ®Google Scholar
• Li N, Taylor LS. (2018). Tailoring supersaturation from amorphous solid dispersions. J Control Release 279:114–25.
   PubMed Web of Science ®Google Scholar
• Lipp R. (2013). The innovator pipeline: bioavailability challenges and advanced oral drug delivery opportunities. Am Pharm Rev 16:10–16.
   Google Scholar
• Liu C, Liu Z, Chen Y, et al. (2018). Oral bioavailability enhancement of β-lapachone, a poorly soluble fast crystallizer, by cocrystal, amorphous solid dispersion, and crystalline solid dispersion. Eur J Pharm Biopharm 124:73–81.
   PubMed Web of Science ®Google Scholar
• Luo C, Wu W, Lin X, et al. (2019). A novel tanshinone IIA/chitosan solid dispersion: preparation, characterization and cytotoxicity evaluation. J Drug Deliv Sci Technol 49:260–7.
   Web of Science ®Google Scholar
• Ma Y, He H, Fan W, et al. (2017). In vivo fate of biomimetic mixed micelles as nanocarriers for bioavailability enhancement of lipid–drug conjugates. ACS Biomater Sci Eng 3:2399–409.
   PubMed Web of Science ®Google Scholar
• Mahlin D, Ponnambalam S, Heidarian Höckerfelt M, Bergström CAS. (2011). Toward in silico prediction of glass-forming ability from molecular structure alone: a screening tool in early drug development. Mol Pharm 8:498–506.
   PubMed Web of Science ®Google Scholar
• Maibaum L, Dinner AR, Chandler D. (2004). Micelle formation and the hydrophobic effect. J Phys Chem B 108:6778–81.
   Web of Science ®Google Scholar
• Manna L, Banchero M, Sola D, et al. (2007). Impregnation of PVP microparticles with ketoprofen in the presence of supercritical CO2. J Supercrit Fluids 42:378–84.
   Web of Science ®Google Scholar
• Marchetti S, Stuurman F, Koolen S, et al. (2012). Phase I study of weekly oral docetaxel (ModraDoc001) plus ritonavir in patients with advanced solid tumors. J Clin Oncol 30:2550.
   Web of Science ®Google Scholar
• Meng F, Ferreira R, Zhang F. (2019). Effect of surfactant level on properties of celecoxib amorphous solid dispersions. J Drug Deliv Sci Technol 49:301–7.
   Web of Science ®Google Scholar
• Miao L, Liang Y, Pan W, et al. (2019). Effect of supersaturation on the oral bioavailability of paclitaxel/polymer amorphous solid dispersion. Drug Deliv Transl Res 9:344–56.
   PubMed Web of Science ®Google Scholar
• Miller JM, Beig A, Carr RA, et al. (2012a). A win–win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability. Mol Pharm 9:2009–16.
   PubMed Web of Science ®Google Scholar
• Miller JM, Beig A, Carr RA, et al. (2012b). The solubility–permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations. Mol Pharm 9:581–90.
   PubMedGoogle Scholar
• Miller JM, Beig A, Krieg BJ, et al. (2011). The solubility–permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation. Mol Pharm 8:1848–56.
   PubMed Web of Science ®Google Scholar
• Mitra A, Li L, Marsac P, et al. (2016). Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug. Int J Pharm 505:107–14.
   PubMedGoogle Scholar
• Moes J, Koolen S, Huitema A, et al. (2013). Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel. Eur J Pharm Biopharm 83:87–94.
   PubMed Web of Science ®Google Scholar
• Moes JJ, Koolen SLW, Huitema ADR, et al. (2011). Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001). Int J Pharm 420:244–50.
   PubMed Web of Science ®Google Scholar
• Mosquera-Giraldo LI, Borca CH, Parker AS, et al. (2018a). Crystallization inhibition properties of cellulose esters and ethers for a group of chemically diverse drugs: experimental and computational insight. Biomacromolecules 19:4593–606.
   PubMed Web of Science ®Google Scholar
• Mosquera-Giraldo LI, Li N, Wilson VR, et al. (2018b). Influence of polymer and drug loading on the release profile and membrane transport of telaprevir. Mol Pharm 15:1700–13.
   PubMedGoogle Scholar
• Mosquera-Giraldo LI, Taylor LS. (2015). Glass–liquid phase separation in highly supersaturated aqueous solutions of telaprevir. Mol Pharm 12:496–503.
   PubMed Web of Science ®Google Scholar
• Mosquera-Giraldo LI, Trasi NS, Taylor LS. (2014). Impact of surfactants on the crystal growth of amorphous celecoxib. Int J Pharm 461:251–7.
   PubMed Web of Science ®Google Scholar
• Newman A. (2015). Pharmaceutical amorphous solid dispersions. Hoboken, NJ: John Wiley & Sons.
   Google Scholar
• Newman A, Knipp G, Zografi G. (2012). Assessing the performance of amorphous solid dispersions. J Pharm Sci 101:1355–77.
   PubMed Web of Science ®Google Scholar
• Othman AA, Cheskin H, Locke C, et al. (2012a). A phase 1 study to evaluate the bioavailability and food effect of 2 solid-dispersion formulations of the TRPV1 antagonist ABT-102, relative to the oral solution formulation, in healthy human volunteers. Clin Pharmacol Drug Dev 1:24–31.
   PubMed Web of Science ®Google Scholar
• Othman AA, Nothaft W, Awni WM, Dutta S. (2012b). Pharmacokinetics of the TRPV1 antagonist ABT-102 in healthy human volunteers: population analysis of data from 3 phase 1 trials. J Clin Pharmacol 52:1028–41.
   PubMed Web of Science ®Google Scholar
• Padden BE, Miller JMM, Robbins T, et al. (2011). Amorphous solid dispersions as enabling formulations for discovery and early development. Am Pharm Rev 14:68–70.
   Google Scholar
• Park K. (2015). Drug release mechanisms from amorphous solid dispersions. J Control Release 211:171.
   PubMed Web of Science ®Google Scholar
• Park JH, Kim DS, Mustapha O, et al. (2018). Comparison of a revaprazan-loaded solid dispersion, solid SNEDDS and inclusion compound: physicochemical characterisation and pharmacokinetics. Colloids Surf B Biointerfaces 162:420–6.
   PubMed Web of Science ®Google Scholar
• Paul SM, Mytelka DS, Dunwiddie CT, et al. (2010). How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov 9:203–14.
   PubMed Web of Science ®Google Scholar
• Polster CS, Wu SJ, Gueorguieva I, Sperry DC. (2015). Mechanism for enhanced absorption of a solid dispersion formulation of LY2300559 using the artificial stomach duodenum model. Mol Pharm 12:1131–40.
   PubMed Web of Science ®Google Scholar
• Prasannaraju Y, Chowdary V, Jayasri V, et al. (2013). Bioavailability and pharmacokinetic studies of rofecoxib solid dispersion. Curr Drug Deliv 10:701–5.
   PubMed Web of Science ®Google Scholar
• Pui Y, Chen Y, Chen H, et al. (2018). Maintaining supersaturation of nimodipine by PVP with or without the presence of sodium lauryl sulfate and sodium taurocholate. Mol Pharm 15:2754–63.
   PubMedGoogle Scholar
• Punčochová K, Ewing AV, Gajdošová M, et al. (2015). Identifying the mechanisms of drug release from amorphous solid dispersions using MRI and ATR-FTIR spectroscopic imaging. Int J Pharm 483:256–67.
   PubMedGoogle Scholar
• Raghavan SL, Trividic A, Davis AF, Hadgraft J. (2001). Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm 212:213–21.
   PubMed Web of Science ®Google Scholar
• Raina SA, Alonzo DE, Zhang GGZ, et al. (2014). Impact of polymers on the crystallization and phase transition kinetics of amorphous nifedipine during dissolution in aqueous media. Mol Pharm 11:3565–76.
   PubMed Web of Science ®Google Scholar
• Raina SA, Eerdenbrugh BV, Alonzo DE, et al. (2015a). Trends in the precipitation and crystallization behavior of supersaturated aqueous solutions of poorly water-soluble drugs assessed using synchrotron radiation. J Pharm Sci 104:1981–92.
   PubMed Web of Science ®Google Scholar
• Raina SA, Zhang GGZ, Alonzo DE, et al. (2015b). Impact of solubilizing additives on supersaturation and membrane transport of drugs. Pharm Res 32:3350–64.
   PubMed Web of Science ®Google Scholar
• Rani S, Mishra S, Sharma M, et al. (2019). Solubility and stability enhancement of curcumin in Soluplus ® polymeric micelles: a spectroscopic study. J Dispers Sci Technol 1–14.
   Web of Science ®Google Scholar
• Saboo S, Mugheirbi NA, Zemlyanov DY, et al. (2019). Congruent release of drug and polymer: a “sweet spot” in the dissolution of amorphous solid dispersions. J Control Release 298:68–82.
   PubMed Web of Science ®Google Scholar
• Sethia S, Squillante E. (2004). In vitro–in vivo evaluation of supercritical processed solid dispersions: permeability and viability assessment in Caco-2 cells. J Pharm Sci 93:2985–93.
   PubMed Web of Science ®Google Scholar
• Shah N, Iyer RM, Mair HJ, et al. (2013). Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation process. J Pharm Sci 102:967–81.
   PubMed Web of Science ®Google Scholar
• Shi C, Tong Q, Fang J, et al. (2015). Preparation, characterization and in vivo studies of amorphous solid dispersion of berberine with hydrogenated phosphatidylcholine. Eur J Pharm Sci 74:11–7.
   PubMed Web of Science ®Google Scholar
• Simonelli AP, Mehta SC, Higuchi WI. (1969). Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates. J Pharm Sci 58:538–49.
   PubMed Web of Science ®Google Scholar
• Six K, Daems T, de Hoon J, et al. (2005). Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion. Eur J Pharm Sci 24:179–86.
   PubMed Web of Science ®Google Scholar
• Solanki NG, Lam K, Tahsin M, et al. (2019). Effects of surfactants on itraconazole-HPMCAS solid dispersion prepared by hot-melt extrusion I: miscibility and drug release. J Pharm Sci 108:1453–65.
   PubMed Web of Science ®Google Scholar
• Stewart AM, Grass ME, Brodeur TJ, et al. (2017). Impact of drug-rich colloids of itraconazole and HPMCAS on membrane flux in vitro and oral bioavailability in rats. Mol Pharm 14:2437–49.
   PubMedGoogle Scholar
• Stewart A, Yates I, Mudie D, et al. (2019). Mechanistic study of belinostat oral absorption from spray-dried dispersions. J Pharm Sci 108:326–36.
   PubMed Web of Science ®Google Scholar
• Sun DD, Lee PI. (2013). Evolution of supersaturation of amorphous pharmaceuticals: the effect of rate of supersaturation generation. Mol Pharm 10:4330–46.
   PubMed Web of Science ®Google Scholar
• Sun DD, Lee PI. (2015). Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers. J Control Release 211:85–93.
   PubMed Web of Science ®Google Scholar
• Szafraniec J, Antosik A, Knapik-Kowalczuk J, et al. (2018). Enhanced dissolution of solid dispersions containing bicalutamide subjected to mechanical stress. Int J Pharm 542:18–26.
   PubMedGoogle Scholar
• Taylor LS, Zhang GGZ. (2016). Physical chemistry of supersaturated solutions and implications for oral absorption. Adv Drug Deliv Rev 101:122–42.
   PubMed Web of Science ®Google Scholar
• Tho I, Liepold B, Rosenberg J, et al. (2010). Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media. Eur J Pharm Sci 40:25–32.
   PubMed Web of Science ®Google Scholar
• Tres F, Posada MM, Hall SD, et al. (2018). Mechanistic understanding of the phase behavior of supersaturated solutions of poorly water-soluble drugs. Int J Pharm 543:29–37.
   PubMedGoogle Scholar
• Tres F, Treacher K, Booth J, et al. (2014). Real time Raman imaging to understand dissolution performance of amorphous solid dispersions. J Control Release 188:53–60.
   PubMed Web of Science ®Google Scholar
• Ueda K, Higashi K, Kataoka M, et al. (2014). Inhibition mechanism of hydroxypropyl methylcellulose acetate succinate on drug crystallization in gastrointestinal fluid and drug permeability from a supersaturated solution. Eur J Pharm Sci 62:293–300.
   PubMed Web of Science ®Google Scholar
• Ueda K, Higashi K, Limwikrant W, et al. (2012). Mechanistic differences in permeation behavior of supersaturated and solubilized solutions of carbamazepine revealed by nuclear magnetic resonance measurements. Mol Pharm 9:3023–33.
   PubMed Web of Science ®Google Scholar
• Ueda K, Higashi K, Moribe K. (2017). Direct NMR monitoring of phase separation behavior of highly supersaturated nifedipine solution stabilized with hypromellose derivatives. Mol Pharm 14:2314–22.
   PubMedGoogle Scholar
• Ueda K, Higashi K, Moribe K. (2019). Mechanistic elucidation of formation of drug-rich amorphous nanodroplets by dissolution of the solid dispersion formulation. Int J Pharm 561:82–92.
   PubMedGoogle Scholar
• Van Eerdenbrugh B, Baird JA, Taylor LS. (2010). Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation—classification and comparison with crystallization tendency from under cooled melts. J Pharm Sci 99:3826–38.
   PubMed Web of Science ®Google Scholar
• Van Eerdenbrugh B, Raina S, Hsieh YL, et al. (2014). Classification of the crystallization behavior of amorphous active pharmaceutical ingredients in aqueous environments. Pharm Res 31:969–82.
   PubMed Web of Science ®Google Scholar
• Verma S, Rudraraju VS. (2015). Wetting kinetics: an alternative approach towards understanding the enhanced dissolution rate for amorphous solid dispersion of a poorly soluble drug. AAPS PharmSciTech 16:1079–90.
   PubMed Web of Science ®Google Scholar
• Vo CLN, Park C, Lee BJ. (2013). Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Biopharm 85:799–813.
   PubMed Web of Science ®Google Scholar
• Wang S, Liu C, Chen Y, et al. (2018). A high-sensitivity HPLC-ELSD method for HPMC-AS quantification and its application in elucidating the release mechanism of HPMC-AS based amorphous solid dispersions. Eur J Pharm Sci 122:303–10.
   PubMed Web of Science ®Google Scholar
• Waring MJ, Arrowsmith J, Leach AR, et al. (2015). An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat Rev Drug Discov 14:475–86.
   PubMed Web of Science ®Google Scholar
• Warren DB, Benameur H, Porter CJH, Pouton CW. (2010). Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility. J Drug Target 18:704–31.
   PubMed Web of Science ®Google Scholar
• Weiss J, Herzog M, König S, et al. (2009). Induction of multiple drug transporters by efavirenz. J Pharmacol Sci 109:242–50.
   PubMed Web of Science ®Google Scholar
• Wishart DS, Feunang YD, Guo AC, et al. (2018). DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46:D1074–D1082.
   PubMed Web of Science ®Google Scholar
• Xia D, Yu H, Tao J, et al. (2016). Supersaturated polymeric micelles for oral cyclosporine A delivery: the role of Soluplus–sodium dodecyl sulfate complex. Colloids Surf B Biointerfaces 141:301–10.
   PubMed Web of Science ®Google Scholar
• Xu S, Dai WG. (2013a). Drug precipitation inhibitors in supersaturable formulations. Int J Pharm 453:36–43.
   PubMed Web of Science ®Google Scholar
• Xu W, Ling P, Zhang T. (2013b). Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J Drug Deliv 2013:1–15.
   Google Scholar
• Yu H, Xia D, Zhu Q, et al. (2013). Supersaturated polymeric micelles for oral cyclosporine A delivery. Eur J Pharm Biopharm 85:1325–36.
   PubMed Web of Science ®Google Scholar
• Zayed R, Kamel AO, Shukr M, El-Shamy AEH. (2012). An in vitro and in vivo comparative study of directly compressed solid dispersions and freeze dried sildenafil citrate sublingual tablets for management of pulmonary arterial hypertension. Acta Pharm 62:411–32.
   PubMed Web of Science ®Google Scholar
• Zhang J, Han R, Chen W, et al. (2018). Analysis of the literature and patents on solid dispersions from 1980 to 2015. Molecules 23.
   Web of Science ®Google Scholar
• Zhang W, Hate SS, Russell DJ, et al. (2019). Impact of surfactant and surfactant–polymer interaction on desupersaturation of clotrimazole. J Pharm Sci 108:3262–71.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Luo Y, et al. (2016). Extruded Soluplus/SIM as an oral delivery system: characterization, interactions, in vitro and in vivo evaluations. Drug Deliv 23:1902–11.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Katai H, Higashi K, et al. (2019). Cryo-TEM and AFM observation of the time-dependent evolution of amorphous probucol nanoparticles formed by the aqueous dispersion of ternary solid dispersions. Mol Pharm 16:2184–98.
   PubMed Web of Science ®Google Scholar
• Zi P, Zhang C, Ju C, et al. (2019). Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant – Soluplus. Eur J Pharm Sci 134:233–45.
   PubMed Web of Science ®Google Scholar